Sarpogrelate hydrochloride 50mg tablets are a generic formulation containing Sarpogrelate hydrochloride, which acts as a selective 5-HT2A receptor antagonist to inhibit platelet aggregation and vasoconstriction, thereby improving blood flow. It is used to address ischemic symptoms related to chronic arterial occlusion. The standard is 50mg per tablet (YJ code: 3399006F1018).
Sarpogrelate hydrochloride 50mg tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).